CPHI Online is the largest global marketplace in the pharma ingredients industry
-
Products551,744
-
Companies7,781
-
Articles11,636
-
Events8
-
Webinars342
How does it work
CPHI Online is a global marketplace.
The place where global Pharma professionals come to source new partners, look for products and solutions and make connections – all year round. It’s also a go-to place to learn about the latest trends, developments and news in the Pharma industry.
If your company wants to do business with the global Pharma industry, this is the place to be.
Why CPHI Online
CPHI Online is the largest global marketplace where the pharma community comes to source new partners, showcase products and solutions, and make connections.
-
Direct access to your target Pharma audience
-
Effective reporting
-
Multi or single channel campaigns
-
Measurable communications and results
-
Scalable multi-channel campaigns
-
Build brand credibility
-
Generate leads
-
Access to expert analysts
-
Promotional campaign around your content
-
Innovative and memorable content
Trusted by over 7,000 pharma companies, including:
Top Products
CPHI Pharmaceutical Products, Companies and News
News Trump's generic drug tariffs set to reshape global pharmaceutical supply chains
The US president has announced plans to impose tariffs of up to 200% on imported generic medicines from August 2028, giving manufacturers a two-year window to establish domestic production facilities. The move threatens to upend a global supply chain t...
22 Jul 2026
News Building Safer, More Responsible Pharmaceutical Supply Chains: PSCI Global Audit Insights
The Pharmaceutical Supply Chain Initiative (PSCI) has released its seventh annual Audit Findings Analysis Report, offering unprecedented insights into supplier practices across the global pharmaceutical and healthcare industry.With a record-breaking 24...
8 Jul 2026
News Federal judge blocks Colorado's unprecedented price cap on Amgen's Enbrel
A US federal court has halted Colorado's attempt to impose a US$31,200 annual price cap on Amgen's arthritis drug Enbrel, ruling that the pharmaceutical company would likely suffer irreparable harm. The decision represents a significant blow to...
2 Jul 2026



